Teva launches generic Symmetrel

NORTH WALES, Penn. — Teva Pharmaceuticals recently launched its generic of Symmetrel (amantadine hydrochloride). The drug is indicated to treat and prevent influenza A and as a treatment for parkinsonism and drug-induced extrapyramidal reactions. 

 

“Our customers count on Teva for a continuous supply of new generic products,” states Maureen Cavanaugh, Chief Operating Officer, North America Generics. “With the launch of Amantadine Hydrochloride Tablets, we add another quality product to our broad line of affordable generic pharmaceuticals.”

 

Teva’s generic is available in 100-mg dosage strength in 100-tablet bottles.